Skip to main content
SpringerLink
Log in

Endoscopic Management of Acute  Non-variceal Upper Gastrointestinal Hemorrhage

  • Reference work entry
  • First Online:
Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy

  • 129 Accesses

Abstract

The most common causes of acute upper gastrointestinal hemorrhage (UGIH) are non-variceal. These include gastric and duodenal peptic ulcers, mucosal erosive disease of the esophagus/stomach/duodenum, malignancy, Mallory-Weiss syndrome, Dieulafoy’s lesion, “other” diagnosis, or no identifiable cause. This chapter focuses on the pre-endoscopic, endoscopic, and post-endoscopic management of patients presenting with acute non-variceal upper gastrointestinal hemorrhage, specifically peptic ulcer hemorrhage.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 699.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 849.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. van Leerdam ME (2008) Epidemiology of acute upper gastrointestinal bleeding. Best Pract Res Clin Gastroenterol 22:209–224

    Article  PubMed  Google Scholar 

  2. Hearnshaw SA, Logan RF, Lowe D et al (2011) Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut 60:1327–1335

    Article  PubMed  Google Scholar 

  3. Kumar NL, Travis AC, Saltzman JR (2016) Initial management and timing of endoscopy in nonvariceal upper GI bleeding. Gastrointest Endosc 84:10–17

    Article  PubMed  Google Scholar 

  4. Hayat U, Lee PJ, Ullah H et al (2017) Association of prophylactic endotracheal intubation in critically ill patients with upper GI bleeding and cardiopulmonary unplanned events. Gastrointest Endosc 86:500–509

    Article  PubMed  Google Scholar 

  5. Laine L, Jensen DM (2012) Management of patients with ulcer bleeding. Am J Gastroenterol 107:345–360

    Article  CAS  PubMed  Google Scholar 

  6. Gralnek IM, Dumonceau JM, Kuipers EJ et al (2015) Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 47:1–46

    Article  Google Scholar 

  7. Sung JJY, Chui PWY, Chan FKL et al (2018) Asia-Pacific working group consensus on non-variceal upper gastrointestinal bleeding: an update 2018. Gut 67:1757–1768

    Article  PubMed  Google Scholar 

  8. Barkun AN, Almadi M, Kuipers EJ et al (2019) Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the international consensus group. Ann Intern Med 171:805–822

    Article  PubMed  PubMed Central  Google Scholar 

  9. Blatchford O, Murray WR, Blatchford M (2000) A risk score to predict need for treatment for upper-gastrointestinal haemorrhage. Lancet 356(9238):1318–1321

    Article  CAS  PubMed  Google Scholar 

  10. Rockall TA, Logan RF, Devlin HB et al (1996) Risk assessment after acute upper gastrointestinal haemorrhage. Gut 38:316–321

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Saltzman JR, Tabak YP, Hyett BH et al (2011) A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding. Gastrointest Endosc 74:1215–1224

    Article  PubMed  Google Scholar 

  12. de Groot NL, Bosman JH, Siersema PD et al (2012) Prediction scores in gastrointestinal bleeding: a systematic review and quantitative appraisal. Endoscopy 44:731–739

    Article  PubMed  Google Scholar 

  13. Liang PS, Saltzman JR (2014) A national survey on the initial management of upper gastrointestinal bleeding. J Clin Gastroenterol 48:93–98

    Article  Google Scholar 

  14. Villanueva C, Colomo A, Bosch A et al (2013) Transfusion strategies for acute upper gastrointestinal bleeding. N Engl J Med 368:11–21

    Article  CAS  PubMed  Google Scholar 

  15. Odutayo A, Desborough MJ, Trivella M et al (2017) Restrictive versus liberal blood transfusion for gastrointestinal bleeding: a systematic review and meta-analysis of randomised controlled trials. Lancet Gastroenterol Hepatol 2:354–360

    Article  PubMed  Google Scholar 

  16. Aljebreen AM, Fallone CA, Barkun AN (2004) Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper GI bleeding. Gastrointest Endosc 59:172–178

    Article  PubMed  Google Scholar 

  17. Singer AJ, Richman PB, Kowalska A et al (1999) Comparison of patient and practitioner assessments of pain from commonly performed emergency department procedures. Ann Emerg Med 33:652–658

    CAS  PubMed  Google Scholar 

  18. Huang ES, Karsan S, Kanwal F et al (2011) Impact of nasogastric lavage on outcomes in acute GI bleeding. Gastrointest Endosc 74:971–980

    Article  PubMed  Google Scholar 

  19. Rockey DC, Ahn C, de Melo SW Jr (2017) Randomized pragmatic trial of nasogastric tube placement in patients with upper gastrointestinal tract bleeding. J Investig Med 65:759–764

    Article  PubMed  Google Scholar 

  20. Lau JY, Leung WK, Wu JC et al (2007) Omeprazole before endoscopy in patients with gastrointestinal bleeding. N Engl J Med 356:1631–1640

    Article  CAS  PubMed  Google Scholar 

  21. Sreedharan A, Martin J, Leontiadis GI et al (2010) Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding. Cochrane Database Syst Rev 7:CD005415

    Google Scholar 

  22. Tsoi KKF, Lau JYW, Sung JJY (2008) Cost-effectiveness analysis of high-dose omeprazole infusion before endoscopy for patients with upper-GI bleeding. Gastrointest Endosc 67:1056–1063

    Article  PubMed  Google Scholar 

  23. Lu Y, Adam V, Teich V et al (2016) Timing or dosing of intravenous proton pump inhibitors in acute upper gastrointestinal bleeding has low impact on cCosts. Am J Gastroenterol 111:1389–1398

    Article  CAS  PubMed  Google Scholar 

  24. Winstead NS, Wilcox CM (2007) Erythromycin prior to endoscopy for acute upper gastrointestinal haemorrhage: a cost–effectiveness analysis. Aliment Pharmacol Ther 26:1371–1377

    Article  CAS  PubMed  Google Scholar 

  25. Radaelli F, Paggi S, Terruzzi V et al (2011) Management of warfarin-associated coagulopathy in patients with acute gastrointestinal bleeding: a cross sectional physician survey of current practice. Dig Liver Dis 43:444–447

    Article  PubMed  Google Scholar 

  26. Tran HA, Chunilal SD, Harper PL et al (2013) An update of consensus guidelines for warfarin reversal. Med J Aust 198:198–199

    Article  PubMed  Google Scholar 

  27. Patriquin C, Crowther M (2011) Treatment of warfarin-associated coagulopathy with vitamin K. Expert Rev Hematol 4:657–665

    Article  CAS  PubMed  Google Scholar 

  28. Dentali F, Marchesi C, Giorgi Pierfranceschi M et al (2011) Safety of prothrombin complex concentrates for rapid anticoagulation reversal of vitamin K antagonists. A meta-analysis. Thromb Haemost 106:429–438

    Article  CAS  PubMed  Google Scholar 

  29. Johansen M, Wikkelso A, Lunde J et al (2015) Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev 7:CD010555

    Google Scholar 

  30. Choudari CP, Rajgopal C, Palmer KR (1994) Acute gastrointestinal haemorrhage in anticoagulated patients: diagnoses and response to endoscopic treatment. Gut 35:464–466

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Chai-Adisaksopha C, Crowther M, Isayama T et al (2014) The impact of bleeding complications in patients receiving target-specific oral anticoagulants: a systematic review and meta-analysis. Blood 124:2450–2458

    Article  CAS  PubMed  Google Scholar 

  32. Desai J, Kolb JM, Weitz JI et al (2013) Gastrointestinal bleeding with the new oral anticoagulants – defining the issues and the management strategies. Thromb Haemost 110:205–212

    Article  CAS  PubMed  Google Scholar 

  33. Makris M, Van Veen JJ, Tait CR, … British Committee for Standards in Haematology (2013) Guideline on the management of bleeding in patients on antithrombotic agents. Br J Haematol 160:35–46

    Google Scholar 

  34. Fawole A, Daw HA, Crowther MA (2013) Practical management of bleeding due to the anti-coagulants dabigatran, rivaroxaban, and apixaban. Cleve Clin J Med 80:443–451

    Article  PubMed  Google Scholar 

  35. Pollack CV Jr, Reilly PA, Bernstein R et al (2015) Design and rationale for RE-VERSE AD: a phase 3 study of idarucizumab, a specific reversal agent for dabigatran. Thromb Haemost 114:198–205

    Article  PubMed  Google Scholar 

  36. Boustiere C, Veitch A, Vanbiervliet G et al (2011) Endoscopy and antiplatelet agents. European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 43:445–461

    Article  CAS  PubMed  Google Scholar 

  37. Sung JJY, Lau JYW, Ching JYL et al (2010) Continuation of low dose aspirin therapy in peptic ulcer bleeding: a randomized trial. Ann Intern Med 152:1–9

    Article  PubMed  Google Scholar 

  38. Derogar M, Sandblom G, Lundell L et al (2013) Discontinuation of low dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Clin Gastroenterol Hepatol 11:38–42

    Article  CAS  PubMed  Google Scholar 

  39. Liu C-P, Chen W-C, Lai K-H et al (2012) Esomeprazole alone compared with esomeprazole plus aspirin for the treatment of aspirin-related peptic ulcers. Am J Gastroenterol 107:1022–1029

    Article  CAS  PubMed  Google Scholar 

  40. Ng FH, Wong BCY, Wong SY et al (2004) Clopidogrel plus omeprazole compared with aspirin plus omeprazole for aspirin-induced symptomatic peptic ulcers/erosions with low to moderate bleeding/re-bleeding risk – a single-blind, randomized controlled study. Aliment Pharmacol Ther 19:359–365

    Article  CAS  PubMed  Google Scholar 

  41. Lau JYW, Yuanyuan Y, Tang RSY et al (2020) Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med 382:1299–1308

    Article  PubMed  Google Scholar 

  42. Forrest JA, Finlayson ND, Shearman DJ (1974) Endoscopy in gastrointestinal bleeding. Lancet 2:394–397

    Article  CAS  PubMed  Google Scholar 

  43. Elmunzer BJ, Young SD, Inadomi JM et al (2008) Systematic review of the predictors of recurrent hemorrhage after endoscopic hemostatic therapy for bleeding peptic ulcers. Am J Gastroenterol 103:2625–2632

    Article  PubMed  Google Scholar 

  44. Lau JY, Sung JJ, Chan AC et al (1997) Stigmata of hemorrhage in bleeding peptic ulcers: an interobserver agreement study among international experts. Gastrointest Endosc 46:33–36

    Article  CAS  PubMed  Google Scholar 

  45. Mondardini A, Barletti C, Rocca G et al (1998) Non-variceal upper gastrointestinal bleeding and Forrest’s classification: diagnostic agreement between endoscopists from the same area. Endoscopy 30:508–512

    Article  CAS  PubMed  Google Scholar 

  46. Lau JYW, Barkun AN, Fan D et al (2013) Challenges in the management of acute peptic ulcer bleeding. Lancet 381(9882):2033–2043

    Article  PubMed  Google Scholar 

  47. Lin JH, Wang K, Perng CL et al (1996) Natural history of bleeding peptic ulcers with a tightly adherent blood clot: a prospective observation. Gastrointest Endosc 43:470–473

    Article  CAS  PubMed  Google Scholar 

  48. Jensen DM, Kovacs TO, Jutabha R et al (2002) Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 123:407–413

    Article  PubMed  Google Scholar 

  49. Bleau BL, Gostout CJ, Sherman KE et al (2002) Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy. Gastrointest Endosc 56:1–6

    Article  PubMed  Google Scholar 

  50. Kahi CJ, Jensen DM, Sung JJY et al (2005) Endoscopic therapy versus medical therapy for bleeding peptic ulcer with adherent clot: a meta-analysis. Gastroenterology 129:855–862

    Article  PubMed  Google Scholar 

  51. Sung J, Chan F, Lau J et al (2003) The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 139:237–243

    Article  CAS  PubMed  Google Scholar 

  52. Laine L, McQuaid KR (2009) Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 7:33–47

    Article  PubMed  Google Scholar 

  53. Holster IL, van Beusekom HM, Kuipers EJ et al (2015) Effects of a hemostatic powder hemospray on coagulation and clot formation. Endoscopy 47:638–645

    Article  PubMed  Google Scholar 

  54. Sung JJ, Luo D, Wu JC et al (2011) Early clinical experience of the safety and effectiveness of hemospray in achieving hemostasis in patients with acute peptic ulcer bleeding. Endoscopy 43:291–295

    Article  CAS  PubMed  Google Scholar 

  55. Smith LA, Stanley AJ, Bergman JJ et al (2014) Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the Survey to Evaluate the Application of Hemospray in the Luminal Tract. J Clin Gastroenterol 48:89–92

    Article  Google Scholar 

  56. Martínez-Alcalá A, Mönkemüller K (2018) Emerging endoscopic treatments for nonvariceal upper gastrointestinal hemorrhage. Gastrointest Endosc Clin N Am 28:307–320

    Article  PubMed  Google Scholar 

  57. Kirschniak A, Kratt T, Stuker D et al (2007) A new endoscopic over-the-scope clip system for treatment of lesions and bleeding in the GI tract: first clinical experiences. Gastrointest Endosc 66:162–167

    Article  PubMed  Google Scholar 

  58. Mönkemüller K, Peter S, Toshniwal J, Popa D, Zabielski M, Stahl RD, Ramesh J, Wilcox CM (2014) Multipurpose use of the “bear claw” (over-the-scope-clip system) to treat endoluminal gastrointestinal disorders. Dig Endosc 26:350–357

    Article  PubMed  Google Scholar 

  59. Dinelli M, Omazzi B, Andreozzi P et al (2017) First clinical experiences with a novel endoscopic over-the-scope clip system. Endosc Int Open 5:151–156

    Article  Google Scholar 

  60. Laine L, Freeman M, Cohen H (1994) Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers. Gastrointest Endosc 40:411–417

    Article  CAS  PubMed  Google Scholar 

  61. Beckly DE, Casebow MP, Pettengell KE (1982) The use of a Doppler ultrasound probe for localizing arterial blood flow during upper gastrointestinal endoscopy. Endoscopy 14:146–147

    Article  CAS  PubMed  Google Scholar 

  62. Wong RCK (2004) Technology review: Endoscopic Doppler ultrasound probe for acute peptic ulcer hemorrhage. Gastrointest Endosc 60:804–812

    Article  PubMed  Google Scholar 

  63. Jensen DM, Ohning GV, Kovacs TOG et al (2016) Doppler endoscopic probe as a guide to risk stratification and definitive hemostasis of peptic ulcer bleeding. Gastrointest Endosc 83:129–136

    Article  PubMed  Google Scholar 

  64. Jensen DM, Kovacs TOG, Ohning GV et al (2017) Doppler endoscopic probe monitoring of blood flow improves risk stratification and outcomes of patients with severe nonvariceal upper gastrointestinal hemorrhage. Gastroenterology 152:1310–1318

    Article  PubMed  Google Scholar 

  65. Nayor J, Salzman JR (2017) Should we all be using the Doppler endoscopic probe in nonvariceal upper gastrointestinal bleeding? Gastroenterology 152:1280–1282

    Article  PubMed  Google Scholar 

  66. ASGE Technology Committee, Conway JD, Adler DG et al (2009) Endoscopic hemostatic devices. Gastrointest Endosc 69:987–996

    Article  Google Scholar 

  67. Ginsberg GG, Barkun AN, Bosco JJ et al (2002) The argon plasma coagulator. Gastrointest Endosc 55:807–810

    Article  PubMed  Google Scholar 

  68. Watson JP, Bennett MK, Griffin SM et al (2000) The tissue effect of argon plasma coagulation on esophageal and gastric mucosa. Gastrointest Endosc 52:342–345

    Article  CAS  PubMed  Google Scholar 

  69. Raju GS, Gajula L (2004) Endoclips for GI endoscopy. Gastrointest Endosc 59:267–279

    Article  PubMed  Google Scholar 

  70. Chuttani R, Barkun A, Carpenter S et al (2006) Endoscopic clip application devices. Gastrointest Endosc 63:746–750

    Article  PubMed  Google Scholar 

  71. Kirschniak A, Subotova N, Zieker D et al (2011) The over-the-scope clip (OTSC) for the treatment of gastrointestinal bleeding, perforations, and fistulas. Surg Endosc 25:2901–2905

    Article  PubMed  Google Scholar 

  72. Gottlieb KT, Banerjee S, Barth BA, ASGE Technology Committee et al (2012) Endoscopic closure devices. Gastrointest Endosc 76:244–251

    Article  PubMed  Google Scholar 

  73. Barkun AN, Moosavi S, Martel M (2013) Topical hemostatic agents: a systematic review with particular emphasis on endoscopic application in GI bleeding. Gastrointest Endosc 77:692–700

    Article  PubMed  Google Scholar 

  74. Lu Y, Adam V, Teich V et al (2016) Timing or dosing of intravenous proton pump inhibitors in acute upper gastrointestinal bleeding has low impact on costs. Am J Gastroenterol 111:1389–1398

    Article  CAS  PubMed  Google Scholar 

  75. Ouali SE, Barkun AN, Wyse J et al (2012) Is routine second-look endoscopy effective after endoscopic hemostasis in acute peptic ulcer bleeding? A meta-analysis. Gastrointest Endosc 76:283–292

    Article  PubMed  Google Scholar 

  76. Imperiale TF, Kong N (2012) Second look endoscopy for bleeding peptic ulcer disease: a decision and cost-effectiveness analysis. J Clin Gastroenterol 46:71–75

    Article  Google Scholar 

  77. Lau JYW, Sung JJY, Lam YH et al (1999) Endoscopic retreatment compared with surgery in patients with recurrent bleeding after initial endoscopic control of bleeding ulcer. N Engl J Med 340:751–756

    Article  CAS  PubMed  Google Scholar 

  78. Gisbert JP, Khorrami S, Carballo F et al (2004) Meta-analysis: Helicobacter pylori eradication therapy vs. anti-secretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer. Aliment Pharmacol Ther 19:617–629

    Article  CAS  PubMed  Google Scholar 

  79. Gisbert JP, Calvet X, Cosme A et al (2012) Long-term follow-up of 1,000 patients cured of Helicobacter pylori infection following an episode of peptic ulcer bleeding. Am J Gastroenterol 107:1197–1204

    Article  CAS  PubMed  Google Scholar 

  80. Gisbert JP, Abraira V (2006) Accuracy of Helicobacter pylori diagnostic tests in patients with bleeding peptic ulcer: a systematic review and meta-analysis. Am J Gastroenterol 101:848–863

    Article  PubMed  Google Scholar 

  81. Sánchez-Delgado J, Gené E, Suárez D et al (2011) Has H. pylori prevalence in bleeding peptic ulcer been underestimated? A meta-regression. Am J Gastroenterol 106:398–405

    Article  PubMed  Google Scholar 

  82. Sostres C, Marcén B, Laredo V et al (2019) Risk of rebleeding, vascular events and death after gastrointestinal bleeding in anticoagulant and/or antiplatelet users. Aliment Pharmacol Ther 50:919–929

    Article  CAS  PubMed  Google Scholar 

  83. Staerk L, Lip GY, Olesen JB et al (2015) Stroke and recurrent haemorrhage associated with antithrombotic treatment after gastrointestinal bleeding in patients with atrial fibrillation: nationwide cohort study. BMJ 351

    Google Scholar 

  84. Kido K, Scalese MJ (2017) Management of oral anticoagulation therapy after gastrointestinal bleeding: whether to, when to, and how to restart an anticoagulation therapy. Ann Pharmacother 51:1000–1007

    Article  CAS  PubMed  Google Scholar 

  85. Hernandez I, Zhang Y, Brooks MM et al (2017) Anticoagulation use and clinical outcomes after major bleeding on dabigatran or warfarin in atrial fibrillation. Stroke 48:159–166

    Article  CAS  PubMed  Google Scholar 

  86. Sengupta N, Marshall AL, Jones BA et al (2018) Rebleeding vs thromboembolism after hospitalization for gastrointestinal bleeding in patients on direct oral anticoagulants. Clin Gastroenterol Hepatol 16(12):1893–1900

    Article  PubMed  Google Scholar 

  87. Sengupta N, Feuerstein JD, Patwardhan VR et al (2015) The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study. Am J Gastroenterol 110:328–335

    Article  CAS  PubMed  Google Scholar 

  88. Witt DM, Delate T, Garcia DA et al (2012) Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding. Arch Intern Med 172(19):1484–1491

    Article  CAS  PubMed  Google Scholar 

  89. Chai-Adisaksopha C, Hillis C, Monreal M et al (2015) Thromboembolic events, recurrent bleeding and mortality after resuming anticoagulant following gastrointestinal bleeding. A meta-analysis. Thromb Haemost 114:819–825

    Article  PubMed  Google Scholar 

  90. Little D, Chai-Adisaksopha C, Hillis C et al (2019) Resumption of anticoagulant therapy after anticoagulant-related gastrointestinal bleeding: a systematic review and meta-analysis. Thromb Res 175:102–109

    Article  CAS  PubMed  Google Scholar 

  91. Beyer-Westendorf J, Gelbricht V, Forster K et al (2014) Peri-interventional management of novel oral anticoagulants in daily care: results from the prospective Dresden NOAC registry. Eur Heart J 35:1888–1896

    Article  CAS  PubMed  Google Scholar 

  92. Douketis JD, Healey JS, Brueckmann M et al (2015) Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost 113:625–632

    Article  PubMed  Google Scholar 

  93. Kyaw MH, Chan FKL (2018) Managing antithrombotic agents in the setting of acute gastrointestinal bleeding. Gastrointest Endosc Clin N Am 28:351–361

    Article  PubMed  Google Scholar 

  94. Sibon I, Orgogozo JM (2004) Antiplatelet drug discontinuation is a risk factor for ischemic stroke. Neurology 62:1187–1189

    Article  PubMed  Google Scholar 

  95. Biondi-Zoccai GG, Lotrionte M, Agostoni P et al (2006) A systematic review and meta-analysis on the hazards of discontinuing or not adhering to aspirin among 50,279 patients at risk for coronary artery disease. Eur Heart J 27:2667–2674

    Article  PubMed  Google Scholar 

  96. Garcia-Rodriguez LA, Cea-Soriano L, Martin-Merino E et al (2011) Discontinuation of low dose aspirin and risk of myocardial infarction: case–control study in UK primary care. BMJ 343:d4094

    Article  PubMed Central  Google Scholar 

  97. van Werkum JW, Heestermans AA, Zomer AC et al (2009) Predictors of coronary stent thrombosis: the Dutch Stent Thrombosis Registry. J Am Coll Cardiol 53:1399–1409

    Article  PubMed  Google Scholar 

  98. Eisenberg MJ, Richard PR, Libersan D et al (2009) Safety of short-term discontinuation of antiplatelet therapy in patients with drug-eluting stents. Circulation 119:1634–1642

    Article  CAS  PubMed  Google Scholar 

  99. Park DW, Park SW, Park KH et al (2006) Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98:352–356

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Gastroenterology and Hepatology, Emek Medical Center, Afula, Israel

    Ian M. Gralnek

  2. Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel

    Ian M. Gralnek

Authors
  1. Ian M. Gralnek
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ian M. Gralnek .

Editor information

Editors and Affiliations

  1. Division of Gastroenterology and Gastrointestinal Endoscopy IRCCS, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy

    Pier Alberto Testoni

  2. Digestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan

    Haruhiro Inoue

  3. Department of Gastroenterology and Hepatology, Mayo Clinic Florida, Jacksonville, FL, USA

    Michael B. Wallace

Section Editor information

  1. Gastrointestinal Endoscopy Unit, Vita‐Salute San Raffaele University, Milan, Italy

    Pier Alberto Testoni

Supplementary Electronic Material(s)

Image 1

(DOCX 563 kb)

Image 2

(DOCX 29 kb)

Image 3

(DOCX 27 kb)

Image 4

(DOCX 25 kb)

Image 5

(DOCX 74 kb)

Video 1

(MPG 8625 kb)

Video 2

(WMV 87782 kb)

Video 3

(AVI 38118 kb)

Video 4

(MP4 7761 kb)

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Gralnek, I.M. (2022). Endoscopic Management of Acute  Non-variceal Upper Gastrointestinal Hemorrhage. In: Testoni, P.A., Inoue, H., Wallace, M.B. (eds) Gastrointestinal and Pancreatico-Biliary Diseases: Advanced Diagnostic and Therapeutic Endoscopy. Springer, Cham. https://doi.org/10.1007/978-3-030-56993-8_62

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-56993-8_62

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-56992-1

  • Online ISBN: 978-3-030-56993-8

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation